Dominika Bielak

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron”.

Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron

Nature(2021)10.1038/s41586-022-04399-5

N/A

0DataRank · unranked

533 citations

Hala Alshammary, Johnstone Tcheou, Gagandeep Singh, Ariel Raskin, Hisaaki Kawabata +38 more

Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B.1.617.2, B.1.351, B.1.1.7+E484K and a sub-variant of C.37

medRxiv(2021)10.1101/2021.07.21.21260961

N/A

0DataRank · unranked

18 citations

Hala Alshammary, Gagandeep Singh, Ariel Raskin, Fatima Amanat, Angela A. Amoako +36 more

Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses

Nature Communications(2022)10.1038/s41467-022-32149-8

N/A

0DataRank · unranked

87 citations

Juan Manuel Carreño, George O’Dell, Jessica Tan, Csaba Bajusz, Hiromi Muramatsu +9 more

Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer

Cancer Cell(2022)10.1016/j.ccell.2022.04.012

N/A

0DataRank · unranked

18 citations

Jorge Gómez, Ananda M. Rodilla, Juan Manuel Carreño, Chih–Yuan Hsu, Christian Rolfo +43 more

Nanovaccines Displaying the Influenza Virus Hemagglutinin in an Inverted Orientation Elicit an Enhanced Stalk‐Directed Antibody Response

Advanced Healthcare Materials(2023)10.1002/adhm.202202729

N/A

0DataRank · unranked

39 citations

Juan Manuel Carreño, Dominika Bielak, Ammar Arsiwala, Clara G. Altomare, Chad Varner +5 more

Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection

mBio(2023)10.1128/mbio.02280-23

N/A

0DataRank · unranked

21 citations

Gagandeep Singh, Kaori Sano, Charles Gleason, Komal Srivastava, PARIS study group +24 more

The post-COVID-19 population has a high prevalence of cross-reactive antibodies to spikes from all Orthocoronavirinae genera

mBio(2023)10.1128/mbio.02250-23

N/A

0DataRank · unranked

15 citations

Anass Abbad, Giulio Kleiner, Komal Srivastava, Charles Gleason, PARIS study group +22 more

SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020-2023

medRxiv(2023)10.1101/2023.12.18.23300131

N/A

0DataRank · unranked

2 citations

Abram L. Wagner, Brian Monahan, Daniel Floda, Ana S. Gonzalez‐Reiche, Johnstone Tcheou +14 more

SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase

Immunity(2024)10.1016/j.immuni.2024.01.017

N/A

0DataRank · unranked

144 citations

Juan Manuel Carreño, Charles Gleason, Brian Monahan, Gagandeep Singh, Anass Abbad +48 more

SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020–2023

Nature Communications(2024)10.1038/s41467-024-50052-2

N/A

0DataRank · unranked

17 citations

Abram L. Wagner, Brian Monahan, Gagandeep Singh, Daniel Floda, Ana S. Gonzalez‐Reiche +27 more

SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101474

N/A

0DataRank · unranked

8 citations

Temima Yellin, Gagandeep Singh, M. Fried, Ariel Raskin, Johnstone Tcheou +23 more